The blood peripheral content of the cells of innate and adaptive immunity in patients with brain tumors of various histogenesis

Nikolay I. Lisyanyi, Irina A. Gnedkova, Larisa A. Kot, Viktoriya V. Vaslovich, Anna A. Shmeleva


Objective: To study the changes in blood content of cells of innate and adaptive immunity in patients with brain tumors of various histogenesis.

Materials and metods. The content of leukocytes, lymphocytes, neutrophils and platelets in the blood of 105 patients with cerebral tumors: 67 of neuroectodermal, 20 of mesenchymal and 18 of neuroepithelial origin. As a control, 28 patients with chronic diseases of the nervous system were examined.

Results. The peripheral blood content of cells of the immune system depended on the histogenesis of tumors. The greatest changes were detected in neuroectodermal tumors, whereas an increased level of neutrophils, platelets and decreased concentration of lymphocyte was revealed, and neuroepithelial tumors demonstrated the smallest changes (pituitary adenomas). The ratio of the platelet count to neutrophils or neutrophils to lymphocytes more informatively reflect the immune system state rather than the absolute content of these cells in the blood.

Conclusions. The indicators of the ratio of different cells of the immune system reflects the activation and inhibition of specific parts of the immune system in brain tumors.


immune cells; brain tumors of various histogenesis


1. Zozulya YuA, editor, Vasileva IG, Glavatskiy AYa, Gridina NYa, Dmitrenko VV, Dudchenko AK, Kavsan YaM, Lisyanyy NI, Makeev SS, Malysheva TA, Mikhaylik OM, Nosov AG, Rozumenko VD, Semenova VM, Orlov YuA, Chuvashova OYu, Shamaev MI, Cherchenko AP. Gliomy golovnogo mozga. Kiev: UIPK “EksOb”; 2007. Russian.

2. Lisyanyy NI. Immunologiya i immunoterapiya zlokachestvennykh gliom golovnogo mozga. Kiev: Interservis; 2011. Russian.

3. Lisyany NI, Gnedkova IA, Belskaya LN, Stanetskaya DN, Semenova VM, Malysheva TA, Shmeleva AA, Gnedkova MA. [Content of neoplastic stem CD133+ and CD15+ cells in tumors and lymphocytes in peripheral blood of patients with gliomas of different level anaplasia]. Onkologiya. 2016;18(1):44-47. Russian. Available from:

4. Kim J, Bae JS. Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment. Mediators Inflamm. 2016;2016:6058147. [CrossRef] [PubMed] [PubMed Central]

5. Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014 Mar;33(1):231-69. [CrossRef] [PubMed] [PubMed Central]

6. Rashid F, Waraich N, Bhatti I, Saha S, Khan RN, Ahmed J, Leeder PC, Larvin M, Iftikhar SY. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol. 2010 Jan 6;8:1. [CrossRef] [PubMed] [PubMed Central]

7. Han S, Liu Y, Li Q, Li Z, Hou H, Wu A. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer. 2015 Sep 4;15:617. [CrossRef] [PubMed] [PubMed Central]

8. Cho KM, Park H, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer. Oncotarget. 2017 Jan 10;8(2):2329-2341. [CrossRef] [PubMed] [PubMed Central]

9. Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011 Jul;13(7):499-503. [CrossRef] [PubMed]

10. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3-4):215-20. [CrossRef] [PubMed]

11. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009 Feb;137(2):425-8. [CrossRef] [PubMed]

12. Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L. Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas. Onco Targets Ther. 2016 Oct 11;9:6111-6117. eCollection 2016. [CrossRef] [PubMed] [PubMed Central]

13. Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O’Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O’Reilly S. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol. 2013 Aug;114(1):149-54. [CrossRef] [PubMed]

14. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ, Lee JH. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012 May;17(3):216-22. [CrossRef] [PubMed]

15. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009 Apr;197(4):466-72. [CrossRef] [PubMed]

16. Matsko D.E., Korshunov A.G. Atlas opukholey tsentral’noy nervnoy sistemy (gistologicheskoe stroenie). St. Petersburg: Polenov Russian Scienific Research Institute of Neurosurgery; 1998. Russian.

GOST Style Citations

Copyright (c) 2017 Nikolay I. Lisyanyi, Irina A. Gnedkova, Larisa A. Kot, Viktoriya V. Vaslovich, Anna A. Shmeleva

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.